Survival of cancer patients with pre-existing heart disease
- PMID: 35922767
- PMCID: PMC9351236
- DOI: 10.1186/s12885-022-09944-z
Survival of cancer patients with pre-existing heart disease
Abstract
Background: While cancer outcomes have improved over time, in Northern Ireland they continue to lag behind those of many other developed economies. The role of comorbid conditions has been suggested as a potential contributory factor in this but issues of data comparability across jurisdictions has inhibited efforts to explore relationships. We use data from a single jurisdiction of the UK using data from - the Northern Ireland Cancer Registry (NICR), to examine the association between mortality (all-cause and cancer specific) and pre-existing cardiovascular diseases among patients with cancer.
Materials and methods: All patients diagnosed with cancer (excluding non-melanoma skin cancer) between 2011 and 2014 were identified from Registry records. Those with a pre-existing diagnosis of cardiovascular diseases were identified by record linkage with patient hospital discharge data using ICD10 codes. Survival following diagnosis was examined using descriptive statistics and Cox proportional hazards regression analyses. Analyses examined all-cause mortality and cancer specific mortality for lung, colorectal, breast and prostate cancer. As well as cardiovascular diseases, regression models controlled for age, gender (where appropriate), deprivation (as quintiles), stage at diagnosis and other comorbidities.
Results: Almost 35,000 incident cancer cases were diagnosed during the study period of which approximately 23% had a prior heart condition. The pan-cancer hazard ratio for death in the presence of pre-existing cardiovascular diseases was 1.28 (95% CI: 1.18-1.40). All-cause and cancer specific mortality was higher for patients with cardiovascular diseases across lung, female breast, prostate and colorectal cancer groups after controlling for age, gender (where appropriate), deprivation (as quintiles), stage at diagnosis and other comorbidities.
Conclusion: Pre-existing morbidity may restrict the treatment of cancer for many patients. In this cohort, cancer patients with pre-existing cardiovascular diseases had poorer outcomes than those without cardiovascular diseases. A high prevalence of cardiovascular diseases may contribute to poorer cancer outcomes at a national level.
Keywords: cancer; pre-existing cardiovascular disease; survival.
© 2022. The Author(s).
Conflict of interest statement
The authors report no competing interests
Figures


Similar articles
-
Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities.Eur Urol. 2020 Feb;77(2):158-166. doi: 10.1016/j.eururo.2019.07.031. Epub 2019 Aug 13. Eur Urol. 2020. PMID: 31420248 Free PMC article.
-
Assessing the impact of comorbid illnesses on death within 10 years in prostate cancer treatment candidates.Cancer. 2011 Sep 1;117(17):3943-52. doi: 10.1002/cncr.25984. Epub 2011 Feb 24. Cancer. 2011. PMID: 21858801
-
Trends in the prevalence of malignancy among patients admitted with acute heart failure and associated outcomes: a nationwide population-based study.Heart Fail Rev. 2019 Nov;24(6):989-995. doi: 10.1007/s10741-019-09808-y. Heart Fail Rev. 2019. PMID: 31175492 Review.
-
Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.Dan Med J. 2018 Apr;65(4):B5454. Dan Med J. 2018. PMID: 29619932 Review.
-
The effect of comorbidities on outcomes in colorectal cancer survivors: a population-based cohort study.J Cancer Surviv. 2018 Dec;12(6):733-743. doi: 10.1007/s11764-018-0710-z. Epub 2018 Sep 6. J Cancer Surviv. 2018. PMID: 30191524
Cited by
-
Stage at diagnosis and breast cancer-specific mortality in breast cancer patients treated with antidepressants, anxiolytics, and antipsychotics: a population-based cohort study from Northern Ireland.Breast Cancer Res Treat. 2025 Aug;213(1):137-150. doi: 10.1007/s10549-025-07766-8. Epub 2025 Jul 5. Breast Cancer Res Treat. 2025. PMID: 40616690 Free PMC article.
-
Association between increased C-reactive protein and cardiovascular disease among patients with rectal cancer.Front Oncol. 2023 Nov 22;13:1287619. doi: 10.3389/fonc.2023.1287619. eCollection 2023. Front Oncol. 2023. PMID: 38074681 Free PMC article.
-
The impact of different dietary flavonoids on the risk of coronary heart disease in cancer patients and that on the prognosis of patients with cancer and coronary heart disease.Eur J Cancer Prev. 2025 May 1;34(3):214-220. doi: 10.1097/CEJ.0000000000000928. Epub 2024 Oct 9. Eur J Cancer Prev. 2025. PMID: 39388175 Free PMC article.
-
Lung cancer and risk of cardiovascular mortality.Front Cardiovasc Med. 2025 Jan 6;11:1491912. doi: 10.3389/fcvm.2024.1491912. eCollection 2024. Front Cardiovasc Med. 2025. PMID: 39834733 Free PMC article.
-
Prognostic impact of coexisting cardiovascular disease in patients with cancer: A multicenter retrospective cohort study.Heliyon. 2024 Feb 5;10(3):e25594. doi: 10.1016/j.heliyon.2024.e25594. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38356609 Free PMC article.
References
-
- Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2011;377:127–138. doi: 10.1016/S0140-6736(10)62231-3. - DOI - PMC - PubMed
-
- Wong, M.C.S., Lao, X.Q., Ho, KF. et al. Incidence and mortality of lung cancer: global trends and association with socioeconomic status. Sci Rep 7, 14300 (2017). https://doi.org/10.1038/s41598-017-14513-7 - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials